Correction to the PRoFESS Trial Paper by Diener et al. (Cerebrovasc Dis 2007;23:368–380)

Publisher： Karger

E-ISSN： 1421-9786|25|1-2|192-192

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.25, Iss.1-2, 2008-01, pp. : 192-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Retraction Statement. Paper ‘Low-Dose Vitamin D Prevents Muscular Atrophy and Reduces Falls and Hip Fractures in Women after Stroke: A Randomized Controlled Trial' by Sato et al. Cerebrovasc Dis 2005;20:187-192

By  

Cerebrovascular Diseases, Vol. 44, Iss. 3-4, 2017-09 ,pp. : 240-240

Karger

Access to resources Recommend Favorite

A New Option for Therapeutic Management of Patients with Cerebrovascular Disease: A Closer Look at the PRoFESS Trial

By Volpe Massimo  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 3, 2008-01 ,pp. : 105-107

Adis International

Access to resources Recommend Favorite

Sekundärprophylaxe des Schlaganfalls nach PRoFESS und SPARCL

By Sander D.  

Der Internist, Vol. 50, Iss. 11, 2009-11 ,pp. : 1227-1238

Springer Publishing Company

Access to resources Recommend Favorite

Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)

By  

Cerebrovascular Diseases, Vol. 23, Iss. 5-6, 2007-02 ,pp. : 368-380

Karger

Access to resources Recommend Favorite

Discontinuation of Antiplatelet Study Medication and Risk of Recurrent Stroke and Cardiovascular Events: Results from the PRoFESS Study

By  

Cerebrovascular Diseases, Vol. 35, Iss. 6, 2013-06 ,pp. : 538-543

Karger

Access to resources Recommend Favorite